Enzon Pharmaceuticals (ENZN)
Enzon Pharmaceuticals EV / EBIT
View ENZN EV / EBIT with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
About EV / EBIT
EV / EBIT is the enterprise value of a company divided by its earnings before interest and taxes.
It is a common valuation multiple for investors who are looking to buy out all stakeholders, especially those of companies with non-equity financing.
For details about how YCharts calculates enterprise value and EBIT, click into the glossary entry and look at each component individually.
Learn More
You may also be interested in these ENZN related companies
ENZN News
$ENZN filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3FPH
about 53 days ago by MarketBrief
about 53 days ago by MarketBrief
Icahn Capital's George Hebard Named as Director on Enzon Pharma (ENZN) Board
Feb 28, 5:17PM Street Insider
Feb 28, 5:17PM Street Insider
@TER_Intraday nice Fry Pan bottom in $ENZN since early Dec. Thanks for that.
about 123 days ago by 1nvestor
about 123 days ago by 1nvestor
EBR: Watchlist/worksheet/3Trading Ideas: $POT $IACI $ENZN http://stks.co/27m6
about 123 days ago by TER_Intraday
about 123 days ago by TER_Intraday
$ENZN http://stks.co/1VXa Biotech name. Flagging right under the 50MA. Watch the $7.15 level.
about 168 days ago by VexTrades
about 168 days ago by VexTrades
Enzon Presents Data From Phase II PEG-SN38 (EZN-2208) Study in Patients With Metastatic Breast Cancer
Dec 08, 6:15PM Marketwire
Dec 08, 6:15PM Marketwire
$ENZN http://stks.co/1Q88 Long setup for a short term trade. Tight price action in small wedge after recent strong buy volume
about 174 days ago by ToddinFL
about 174 days ago by ToddinFL
$ENZN http://stks.co/1ONJ Heavy short interest may have been taken out last week. Seth Klarman & Carl Icahn own 30% of shares.
about 175 days ago by drdebt
about 175 days ago by drdebt
Enzon Presents Clinical and Preclinical Data on mRNA Antagonists at 2011 AACR-NCI-EORTC Meeting
Nov 12, 1:00PM Marketwire
Nov 12, 1:00PM Marketwire
Enzon COO Ralph Del Campo steps down, CFO Ana I. Stancic promoted to COO
Oct 17, 4:25PM FlyOnTheWall
Oct 17, 4:25PM FlyOnTheWall
Enzon Pharma (ENZN) Promotes CFO Stancic to COO; Forms Special Committee
Oct 17, 4:14PM Street Insider
Oct 17, 4:14PM Street Insider
Enzon Announces Promotion of CFO Ana I. Stancic to COO; Continues to Serve as CFO
Oct 17, 4:14PM Benzinga
Oct 17, 4:14PM Benzinga
Iridian Asset Management Raises Stake in Enzon Pharmaceuticals, Inc. (ENZN) to 11.6%
Oct 06, 1:47PM Street Insider
Oct 06, 1:47PM Street Insider
Enzon $ENZN to Cut Workforce by 48% to Support R&D Activities, Sees Q3 Charge ~$3M
about 249 days ago by Street_Insider
about 249 days ago by Street_Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ENZN | 6.32 | +0.16 | +2.60% | 305.19M |
| DWSN | 24.95 | +0.07 | +0.28% | 197.60M |
| DWRI | None | None | None | |
| DWM | 39.25 | -0.11 | -0.27% | |
| DWCH | 12.06 | -0.17 | -1.39% | 75.25M |
| DWA | 17.85 | +0.13 | +0.73% | 1.500B |
| DW | 26.41 | -0.21 | -0.79% | 587.36M |
| DVY | 54.98 | -0.09 | -0.16% | |
| DVOX | 1.51 | +0.00 | +0.00% | 15.89M |
| DVN | 60.02 | -0.41 | -0.68% | 24.25B |
